ClinicalTrials.gg
Drug

Spironolactone clinical trials

Also written Aldactone and SC 9420.

studies test it
174
open now
25
in phase 3
37
first study started
2002

How each study uses Spironolactone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Spironolactone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Jan 1960 · ALDACTONE · NDA 012151 (FDA, Drugs@FDA)
European Union
26 May 2023 · Qaialdo · EMEA/H/C/005535 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Spironolactone
118
Spironolactone 25mg
6
Spironolactone (drug)
6
Spironolactone 100mg
5
Spironolactone 50 MG
3

Brand

Aldactone
39
aldactone 25 mg
1

Development codes

SC 9420
2

In one entry with another drug

Given together, or one or the other

Spironolactone + Dapagliflozin
2
spironolactone + furosemide
2
metolazone/spironolactone
2

Studies by the year they started

169 studies that test it; most in 2013 (13); 2 more planned to start later

Studies that test Spironolactone, by start year
YearStudies
20021
20033
20047
20057
20066
20076
20087
20097
201012
20116
20126
201313
201412
20159
20165
20175
20188
20197
20208
20214
202210
20235
20246
20254
20265

Who runs them

Industry 7 · Other 167

Brigham and Women's Hospital (5) · University of Virginia (4) · Vanderbilt University (3) · Instituto Nacional de Cardiologia Ignacio Chavez (3) · Yale University (2) · University of Pennsylvania (2) · Emory University (2) · Sarfez Pharmaceuticals, Inc. (2)

Often tested with

Tested in the same studies.

Eplerenone (5) · Furosemide (5) · Amiloride (5) · Torsemide (4) · Metformin (4) · Dapagliflozin (3) · Carvedilol (3) · Bisoprolol (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test Spironolactone, phase 3 first.

Studies

Open first, then newest update. How each study uses Spironolactone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 174

See all 174 studies that test Spironolactone →

Given beside what is tested · 12 — Spironolactone is usual care or a partner of the new treatment
As the comparator · 19 — what is tested is compared with Spironolactone

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Spironolactone · ClinicalTrials.gg INT008232

  • MeSH (NLM) D013148SpironolactoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 27O7W4T232SPIRONOLACTONEConfirmed FDA, NLM, Wikidata
  • RxNorm 9997Confirmed FDA, Wikidata
  • Wikidata Q422188spironolactoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C840SpironolactoneOne source FDA
  • DrugBank DB00421One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.